The Efficacy of Probiotics as an Adjunct to Treatment of SIBO With Rifaximin

Clinical trial NCT06223685 · COMPLETED

Trial details

NCT number: NCT06223685
Sponsor: Pomeranian Medical University Szczecin
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Irritable Bowel Syndrome Small Intestinal Bacterial Overgrowth SIBO

Start date: 2023-04-01
Primary completion: 2024-08-01
Enrollment: 129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.